Strategies for Validation Extensions - It is essential to understand the critical elements of validation extensions to ensure accurate process or product quality measurements. - BioPharm International

ADVERTISEMENT

Strategies for Validation Extensions
It is essential to understand the critical elements of validation extensions to ensure accurate process or product quality measurements.


BioPharm International


References

1. International Conference on Harmonization. Q2(R1), Validation of analytical procedures: text and methodology. Geneva, Switzerland; 2005, Nov.

2. The Fitness for Purpose of Analytical Method, Eurachem Teddington, UK; 1998. http://www.eurachem.ul.pt/guides/valid.pdf

3. Traceability in Chemical Measurement, Eurachem/CITAC. Teddington, UK; 2003. http://www.eurachem.ul.pt/guides/ EC_Trace_2003.pdf .

5. US Food and Drug Administration. Draft guidance for industry. Analytical procedures and methods validation. Rockville, MD; 2000.

6. Parenteral Drug Association. Technical Report 33, evaluation, validation and Implementation of new microbiological testing methods. Bethesda, MD.

7. European Pharmacopeia. Alternative methods for control of microbiological quality. Supplement 5.5 [07/2006:50106] (December 2005).

8. Krause SO. Validation of analytical methods for biopharmaceuticals—A guide to risk-based validation and implementation strategies. PDA/DHI Publishing; 2007, Apr.

9. US Food and Drug Administration. Guidance for industry PAT—A framework for innovative pharmaceutical development, manufacturing, and quality assurance, Rockville, MD; 2004.

10. ISPE Good Practice Guide: Technology Transfer. International Society for Pharmaceutical Engineering. 2003; Tampa, FL.

11. Statistical Principles for Clinical Trials, ICH E9 (1998). http://www.emea.eu.int/ pdfs/human/ich/036396en.pdf.

12. Points to Consider on Switching Between Superiority and Non-Inferiority, CPMP (2000). http://www.emea.eu.int/pdfs/ human/ewp/ 048299en.pdf.

13. Points to Consider On The Choice Of Non-Inferiority Margin, CPMP (2004).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lundbeck CEO Resigns Due to Code of Conduct Breach
November 24, 2014
GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here